How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Persistent Fever as a Key Mortality Predictor in MRSA Bacteremia

Monoclonal Antibody Reduces Mortality for SARS-CoV-2-Induced Acute Respiratory Distress Syndrome

Addressing the Threat of Candida Infections: Resistance and Management

Recce Pharmaceuticals Reports Positive Data from Phase 2 Study for Gel for ABSSSI

Early Detection of Measles in Wastewater Highlights Silent Transmission Risks

Investigational Staphylococcus aureus Vaccine Begins Trial

Measles Outbreak in Texas Expands to 58 Cases, Hospitalizations Increase

FDA Sets PDUFA Date for Lenacapavir For HIV Prevention

Community Engagement and Data Practices

Wyoming Reports First Case of Avian Influenza

Schedule an Appointment

Quick Links

Patient Forms

Contact Us